Vaccination Policy: It is a health policy that the government adopts for the process of vaccination. Vaccination policies have been developed over the approximately two centuries since the invention of vaccinations with the motive of suppress disease from, or boost a strong immunity system for, the population the government wants to protect. When EPI was established over 40 years ago, its main focus was on vaccinating infants with a limited number of traditional vaccines. Today the vaccine world has changed completely When EPI was established over 40 years ago, its focus was on vaccinating infants with a limited number of traditional vaccines. Today the vaccine world has changed dramatically.
Regulatory Affairs: Although the European Medicines Agency (EMA) and the World Health Organization (WHO) and the United States Food and Drug Administration (USFDA), already must established a Regulatory framework for the guideline for vaccines, the other region across the world are still at a nascent period in creating a Regulatory framework for vaccines at a national level in their own countries. As regulatory compliance for all vaccines requires some special sets of hands-on functional experience and Regulatory expertise knowledge, organizations may find it challenging to navigate through the global Regulatory framework for Vaccines.
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey
Title : Overcoming biophysical characterization challenges of small antigens in dilute vaccine formulations
Eric Kemp, Merck & Co., United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : A combined LC-MS and immunoassay approach to characterize preservative-induced destabilization of human papillomavirus virus-like particles adsorbed to an aluminum-salt adjuvant
Ria T Caringal, University of Kansas, United States